相关实验视频

Updated: Jun 17, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

ncRNAs与PI3K/AKT/mTOR通路的相互作用:对骨髓瘤的影响

Weilin Shao¹, Yan Feng¹, Jin Huang¹

¹Bone and Soft Tissue Tumours Research Centre of Yunnan Province, Department of Orthopaedics, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital, Yunnan Cancer Center), Kunming, Yunnan, 650118, China.

Open life sciences

|August 9, 2024

概括

骨肉瘤 (OS) 的进展与PI3K/AKT/mTOR途径有关. 针对这种途径和非编码RNA (ncRNA) 之间的相互作用,为这种具有挑战性的骨癌提供了新的治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

骨髓瘤 (OS) 是儿童和青少年的主要骨癌,其特征是异质性,转移和不良结果.
复发,转移和多药耐药性显著阻碍OS治疗疗效和患者预后.
在OS中经常观察到PI3K/AKT/mTOR信号通路的异常激活,导致瘤发育和转移.

研究的目的:

审查PI3K/AKT/mTOR途径与骨髓瘤中非编码RNA (ncRNA) 之间的复杂相互作用.
阐明这些相互作用在OS瘤发生,进展和耐药性的作用.
探索这些相互作用作为OS的诊断生物标志物和治疗点的潜力.

主要方法:

对研究PI3K/AKT/mTOR途径在骨髓瘤中的研究的文献综述.
对非编码RNA (ncRNA) 和它们在癌症中的调控作用的研究分析.
在OS的背景下,综合了PI3K/AKT/mTOR途径和ncRNA之间的相互作用的发现.

主要成果:

PI3K/AKT/mTOR通路是OS细胞增殖,迁移和生存的关键调节者.
非编码RNAs (ncRNAs) 调节PI3K/AKT/mTOR通路,影响OS发育和药物敏感性.
特定的ncRNAs可以通过与OS的这种途径相互作用,充当瘤基因或瘤抑制剂.

结论:

在PI3K/AKT/mTOR途径和ncRNAs之间的交叉是骨髓瘤病变发生的关键.
针对这些相互作用,为针对OS的新型治疗策略提供了一个有希望的途径.
对这些ncRNA路径相互作用的进一步研究可能会导致开发有效的生物标志物和骨髓瘤治疗方法.

关键词:

在PI3K/AKT/mTOR中使用.生物标志物生物标志物这种ncRNAsRNAs.骨质肉瘤是骨质肉瘤的一种疾病.治疗目标是治疗的目标.

更多相关视频

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

相关概念视频

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Interactions Between Signaling Pathways

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...